This HTML5 document contains 40 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n8http://linked.opendata.cz/resource/drugbank/drug/DB02713/identifier/chemspider/
n10http://bio2rdf.org/drugbank:
n7http://linked.opendata.cz/resource/drugbank/drug/DB02713/identifier/bindingdb/
n15http://linked.opendata.cz/resource/drugbank/drug/DB02713/identifier/pdb/
admshttp://www.w3.org/ns/adms#
n11http://linked.opendata.cz/resource/drugbank/drug/DB02713/identifier/pubchem-compound/
n12http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n13http://linked.opendata.cz/resource/drugbank/drug/DB02713/identifier/pubchem-substance/
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n14http://linked.opendata.cz/resource/drugbank/drug/DB02713/identifier/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB02713
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n10:DB02713 n12:DB02713
dcterms:title
Acetylamino-Acetic Acid
adms:identifier
n7:50020372 n8:10507 n11:10972 n13:46504798 n14:DB02713 n15:AAC
n3:IUPAC-Name
n4:271B516B-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B5171-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B5170-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B516D-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B516E-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B516F-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B5181-363D-11E5-9242-09173F13E4C5 n4:271B5169-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B516A-363D-11E5-9242-09173F13E4C5 n4:271B5167-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B5168-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B5177-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B5178-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B5172-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B5173-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B5175-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B5174-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B5176-363D-11E5-9242-09173F13E4C5
n3:casRegistryNumber
543-24-8
n3:Bioavailability
n4:271B517D-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B517F-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B5180-363D-11E5-9242-09173F13E4C5
n3:Melting-Point
n4:271B5182-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B517C-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B517B-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B517E-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B516C-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B5179-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B517A-363D-11E5-9242-09173F13E4C5